stavudine has been researched along with Dyslipidemia in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (71.43) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Portilla, J | 1 |
Crane, HM; Feldman, BJ; Grunfeld, C; Kitahata, MM; Lederman, MM; Moore, R; Mugavero, MJ; Rodriguez, B; Saag, MS; Van Rompaey, S; Willig, JH | 1 |
Araújo, FS; Bonolo, PF; Ceccato, MG; Freitas, MI; Souza Neto, AI | 1 |
Aldrovandi, GM; Beretta, S; Giacomet, V; Luraschi, P; Martelli, L; Merlo, M; Mora, S; Rombolà, G; Viganò, A | 1 |
Manfredi, R | 1 |
Antela, A; Domingo, P; Llibre, JM; Miralles, C; Moreno, S; Palacios, R; Pérez-Elías, MJ; Sánchez-de la Rosa, R; Santos, J | 1 |
Bernard, J; Bonnet, E; Fauvel, J; Massip, P; Perret, B; Ruidavets, JB | 1 |
1 review(s) available for stavudine and Dyslipidemia
Article | Year |
---|---|
[Tenofovir as a strategy to avoid or limit adverse effects].
Topics: Adenine; Anemia; Anti-HIV Agents; Antimetabolites; Clinical Trials as Topic; DNA, Mitochondrial; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Glucose Metabolism Disorders; HIV Infections; HIV-1; HIV-Associated Lipodystrophy Syndrome; Humans; Multicenter Studies as Topic; Organophosphonates; Prospective Studies; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Stavudine; Tenofovir; Thymidine; Zidovudine | 2008 |
1 trial(s) available for stavudine and Dyslipidemia
Article | Year |
---|---|
Improvement in dyslipidaemia after switching stavudine to tenofovir and replacing protease inhibitors with efavirenz in HIV-infected children.
Topics: Adenine; Adolescent; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Child; Cyclopropanes; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Lipids; Male; Organophosphonates; Oxazines; Protease Inhibitors; Stavudine; Tenofovir; Treatment Outcome; Viral Load | 2005 |
5 other study(ies) available for stavudine and Dyslipidemia
Article | Year |
---|---|
Impact of NRTIs on lipid levels among a large HIV-infected cohort initiating antiretroviral therapy in clinical care.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cohort Studies; Didanosine; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Reverse Transcriptase Inhibitors; Risk Assessment; Risk Factors; Stavudine | 2011 |
Antiretroviral therapy-associated dyslipidemia in patients from a reference center in Brazil.
Topics: Adolescent; Adult; Aged; Antiretroviral Therapy, Highly Active; Brazil; Cross-Sectional Studies; Drug Therapy, Combination; Dyslipidemias; Female; HIV Infections; HIV Protease Inhibitors; Humans; Lipodystrophy; Male; Middle Aged; Reverse Transcriptase Inhibitors; Statistics, Nonparametric; Stavudine; Treatment Outcome; Young Adult | 2011 |
Improvement of dyslipidemia during different HAART regimens: tenofovir- versus stavudine-containing antiretroviral combinations.
Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Dyslipidemias; HIV Infections; Humans; Organophosphonates; Stavudine; Tenofovir | 2006 |
Sustained improvement of dyslipidaemia in HAART-treated patients replacing stavudine with tenofovir.
Topics: Adenine; Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Prospective Studies; Risk Factors; Stavudine; Tenofovir | 2006 |
Association of APOC3 polymorphisms with both dyslipidemia and lipoatrophy in HAART-receiving patients.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Apolipoprotein C-III; Body Composition; Body Fat Distribution; Cross-Sectional Studies; Dyslipidemias; France; Gene Frequency; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lipoproteins; Male; Middle Aged; Polymorphism, Genetic; Stavudine; Triglycerides | 2008 |